Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Investigation
|
December 2, 2025
Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer
Zheng Zhong, Xinang Cao, Pei-Ju Liao, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay R Anand, Gaith N Droby, Sayali Joseph, et al.
NAR Cancer
|
March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay R Anand, Gaith N Droby, Sayali Joseph, et al.
Cancer Research
|
November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance
Kristina Drizyte-Miller, Seamus E Degan, Ryan D Mouery, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer
Wen-Hsuan Chang, Alec J Vaughan, Addison G Stamey, et al.
Science Translational Medicine
|
October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy
Xiuting Liu, John M Baer, Meredith L Stone, et al.
Cancer Research
|
July 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp, et al.
Science (New York, N.Y.)
|
June 6, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp, et al.
Science Signaling
|
September 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer
Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Investigation
|
December 2, 2025
Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer
Zheng Zhong, Xinang Cao, Pei-Ju Liao, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay R Anand, Gaith N Droby, Sayali Joseph, et al.
NAR Cancer
|
March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
Jay R Anand, Gaith N Droby, Sayali Joseph, et al.
Cancer Research
|
November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor Resistance
Kristina Drizyte-Miller, Seamus E Degan, Ryan D Mouery, et al.
Biorxiv : the Preprint Server for Biology
|
May 4, 2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer
Wen-Hsuan Chang, Alec J Vaughan, Addison G Stamey, et al.
Science Translational Medicine
|
October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy
Xiuting Liu, John M Baer, Meredith L Stone, et al.
Cancer Research
|
July 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp, et al.
Science (New York, N.Y.)
|
June 6, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp, et al.
Science Signaling
|
September 30, 2025
Defining the MYC-regulated transcriptome and kinome that support KRAS- and ERK-dependent growth of pancreatic cancer
Priya S Hibshman, Clint A Stalnecker, Jeffrey A Klomp, et al.
Page
of 2